Jerusalem, Israel

Seth Jonah Salpeter

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Immunyx Pharma Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seth Jonah Salpeter. Retrieved from https://idiyas.com/inventor/seth-jonah-salpeter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Seth Jonah Salpeter

Introduction

Seth Jonah Salpeter is an accomplished inventor based in Jerusalem, Israel. He has made significant contributions to the field of medical science, particularly in the area of neutrophil-associated diseases. His work focuses on developing innovative solutions that can improve patient outcomes.

Latest Patents

Seth holds a patent for "Neutrophil exocytosis inhibitors." This invention is directed to compounds and compositions that can be used for the treatment and prevention of neutrophil-associated diseases or conditions in subjects in need. His patent represents a significant advancement in therapeutic options for these medical conditions. He has 1 patent to his name.

Career Highlights

Seth is currently associated with Immunyx Pharma Ltd., where he continues to work on groundbreaking research and development projects. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.

Collaborations

Seth collaborates with Daryl C Drummond, leveraging their combined expertise to drive innovation in their research endeavors.

Conclusion

Seth Jonah Salpeter's contributions to the field of medical science through his patent and work at Immunyx Pharma Ltd. highlight his commitment to advancing healthcare solutions. His innovative approach to treating neutrophil-associated diseases showcases the potential for significant improvements in patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…